IBDEI0MP ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10202,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,10202,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,10202,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,10203,0)
;;=E11.610^^39^431^9
;;^UTILITY(U,$J,358.3,10203,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10203,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,10203,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,10203,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,10204,0)
;;=E11.618^^39^431^26
;;^UTILITY(U,$J,358.3,10204,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10204,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,10204,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,10204,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,10205,0)
;;=E11.621^^39^431^16
;;^UTILITY(U,$J,358.3,10205,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10205,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,10205,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,10205,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,10206,0)
;;=E11.622^^39^431^31
;;^UTILITY(U,$J,358.3,10206,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10206,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,10206,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,10206,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,10207,0)
;;=E11.628^^39^431^30
;;^UTILITY(U,$J,358.3,10207,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10207,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Compl
;;^UTILITY(U,$J,358.3,10207,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,10207,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,10208,0)
;;=E11.630^^39^431^33
;;^UTILITY(U,$J,358.3,10208,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10208,1,3,0)
;;=3^DM Type 2 w/ Periodontal Disease
;;^UTILITY(U,$J,358.3,10208,1,4,0)
;;=4^E11.630
;;^UTILITY(U,$J,358.3,10208,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,10209,0)
;;=E11.638^^39^431^29
;;^UTILITY(U,$J,358.3,10209,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10209,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,10209,1,4,0)
;;=4^E11.638
;;^UTILITY(U,$J,358.3,10209,2)
;;=^5002660
;;^UTILITY(U,$J,358.3,10210,0)
;;=E11.641^^39^431^20
;;^UTILITY(U,$J,358.3,10210,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10210,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,10210,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,10210,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,10211,0)
;;=E11.649^^39^431^21
;;^UTILITY(U,$J,358.3,10211,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10211,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,10211,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,10211,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,10212,0)
;;=E11.65^^39^431^17
;;^UTILITY(U,$J,358.3,10212,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10212,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,10212,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,10212,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,10213,0)
;;=E11.69^^39^431^32
;;^UTILITY(U,$J,358.3,10213,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10213,1,3,0)
;;=3^DM Type 2 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,10213,1,4,0)
;;=4^E11.69
;;^UTILITY(U,$J,358.3,10213,2)
;;=^5002664
;;^UTILITY(U,$J,358.3,10214,0)
;;=E11.8^^39^431^34
;;^UTILITY(U,$J,358.3,10214,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10214,1,3,0)
;;=3^DM Type 2 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,10214,1,4,0)
;;=4^E11.8
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0MP 3792 printed Apr 09, 2024@21:43:10 Page 2
IBDEI0MP ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10202,1,3,0)
+2 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+3 ;;^UTILITY(U,$J,358.3,10202,1,4,0)
+4 ;;=4^E11.59
+5 ;;^UTILITY(U,$J,358.3,10202,2)
+6 ;;=^5002652
+7 ;;^UTILITY(U,$J,358.3,10203,0)
+8 ;;=E11.610^^39^431^9
+9 ;;^UTILITY(U,$J,358.3,10203,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,10203,1,3,0)
+12 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+13 ;;^UTILITY(U,$J,358.3,10203,1,4,0)
+14 ;;=4^E11.610
+15 ;;^UTILITY(U,$J,358.3,10203,2)
+16 ;;=^5002653
+17 ;;^UTILITY(U,$J,358.3,10204,0)
+18 ;;=E11.618^^39^431^26
+19 ;;^UTILITY(U,$J,358.3,10204,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,10204,1,3,0)
+22 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+23 ;;^UTILITY(U,$J,358.3,10204,1,4,0)
+24 ;;=4^E11.618
+25 ;;^UTILITY(U,$J,358.3,10204,2)
+26 ;;=^5002654
+27 ;;^UTILITY(U,$J,358.3,10205,0)
+28 ;;=E11.621^^39^431^16
+29 ;;^UTILITY(U,$J,358.3,10205,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,10205,1,3,0)
+32 ;;=3^DM Type 2 w/ Foot Ulcer
+33 ;;^UTILITY(U,$J,358.3,10205,1,4,0)
+34 ;;=4^E11.621
+35 ;;^UTILITY(U,$J,358.3,10205,2)
+36 ;;=^5002656
+37 ;;^UTILITY(U,$J,358.3,10206,0)
+38 ;;=E11.622^^39^431^31
+39 ;;^UTILITY(U,$J,358.3,10206,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,10206,1,3,0)
+42 ;;=3^DM Type 2 w/ Oth Skin Ulcer
+43 ;;^UTILITY(U,$J,358.3,10206,1,4,0)
+44 ;;=4^E11.622
+45 ;;^UTILITY(U,$J,358.3,10206,2)
+46 ;;=^5002657
+47 ;;^UTILITY(U,$J,358.3,10207,0)
+48 ;;=E11.628^^39^431^30
+49 ;;^UTILITY(U,$J,358.3,10207,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,10207,1,3,0)
+52 ;;=3^DM Type 2 w/ Oth Skin Compl
+53 ;;^UTILITY(U,$J,358.3,10207,1,4,0)
+54 ;;=4^E11.628
+55 ;;^UTILITY(U,$J,358.3,10207,2)
+56 ;;=^5002658
+57 ;;^UTILITY(U,$J,358.3,10208,0)
+58 ;;=E11.630^^39^431^33
+59 ;;^UTILITY(U,$J,358.3,10208,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,10208,1,3,0)
+62 ;;=3^DM Type 2 w/ Periodontal Disease
+63 ;;^UTILITY(U,$J,358.3,10208,1,4,0)
+64 ;;=4^E11.630
+65 ;;^UTILITY(U,$J,358.3,10208,2)
+66 ;;=^5002659
+67 ;;^UTILITY(U,$J,358.3,10209,0)
+68 ;;=E11.638^^39^431^29
+69 ;;^UTILITY(U,$J,358.3,10209,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,10209,1,3,0)
+72 ;;=3^DM Type 2 w/ Oth Oral Compl
+73 ;;^UTILITY(U,$J,358.3,10209,1,4,0)
+74 ;;=4^E11.638
+75 ;;^UTILITY(U,$J,358.3,10209,2)
+76 ;;=^5002660
+77 ;;^UTILITY(U,$J,358.3,10210,0)
+78 ;;=E11.641^^39^431^20
+79 ;;^UTILITY(U,$J,358.3,10210,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,10210,1,3,0)
+82 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+83 ;;^UTILITY(U,$J,358.3,10210,1,4,0)
+84 ;;=4^E11.641
+85 ;;^UTILITY(U,$J,358.3,10210,2)
+86 ;;=^5002661
+87 ;;^UTILITY(U,$J,358.3,10211,0)
+88 ;;=E11.649^^39^431^21
+89 ;;^UTILITY(U,$J,358.3,10211,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,10211,1,3,0)
+92 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+93 ;;^UTILITY(U,$J,358.3,10211,1,4,0)
+94 ;;=4^E11.649
+95 ;;^UTILITY(U,$J,358.3,10211,2)
+96 ;;=^5002662
+97 ;;^UTILITY(U,$J,358.3,10212,0)
+98 ;;=E11.65^^39^431^17
+99 ;;^UTILITY(U,$J,358.3,10212,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,10212,1,3,0)
+102 ;;=3^DM Type 2 w/ Hyperglycemia
+103 ;;^UTILITY(U,$J,358.3,10212,1,4,0)
+104 ;;=4^E11.65
+105 ;;^UTILITY(U,$J,358.3,10212,2)
+106 ;;=^5002663
+107 ;;^UTILITY(U,$J,358.3,10213,0)
+108 ;;=E11.69^^39^431^32
+109 ;;^UTILITY(U,$J,358.3,10213,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,10213,1,3,0)
+112 ;;=3^DM Type 2 w/ Oth Spec Compl
+113 ;;^UTILITY(U,$J,358.3,10213,1,4,0)
+114 ;;=4^E11.69
+115 ;;^UTILITY(U,$J,358.3,10213,2)
+116 ;;=^5002664
+117 ;;^UTILITY(U,$J,358.3,10214,0)
+118 ;;=E11.8^^39^431^34
+119 ;;^UTILITY(U,$J,358.3,10214,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,10214,1,3,0)
+122 ;;=3^DM Type 2 w/ Unspec Compl
+123 ;;^UTILITY(U,$J,358.3,10214,1,4,0)
+124 ;;=4^E11.8
